BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 22382867)

  • 1. Predictors of 25-hydroxyvitamin D and its association with risk factors for prostate cancer: evidence from the prostate testing for cancer and treatment study.
    Gilbert R; Martin RM; Fraser WD; Lewis S; Donovan J; Hamdy F; Neal DE; Lane JA; Metcalfe C
    Cancer Causes Control; 2012 Apr; 23(4):575-88. PubMed ID: 22382867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations of circulating retinol, vitamin E, and 1,25-dihydroxyvitamin D with prostate cancer diagnosis, stage, and grade.
    Gilbert R; Metcalfe C; Fraser WD; Donovan J; Hamdy F; Neal DE; Lane JA; Martin RM
    Cancer Causes Control; 2012 Nov; 23(11):1865-73. PubMed ID: 22926301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using genetic proxies for lifecourse sun exposure to assess the causal relationship of sun exposure with circulating vitamin d and prostate cancer risk.
    Bonilla C; Gilbert R; Kemp JP; Timpson NJ; Evans DM; Donovan JL; Hamdy FC; Neal DE; Fraser WD; Davey SG; Lewis SJ; Lathrop M; Martin RM
    Cancer Epidemiol Biomarkers Prev; 2013 Apr; 22(4):597-606. PubMed ID: 23441100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations of circulating 25-hydroxyvitamin D with prostate cancer diagnosis, stage and grade.
    Gilbert R; Metcalfe C; Fraser WD; Donovan J; Hamdy F; Neal DE; Lane JA; Martin RM
    Int J Cancer; 2012 Sep; 131(5):1187-96. PubMed ID: 22033893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum vitamin D concentration and prostate cancer risk: a nested case-control study.
    Ahn J; Peters U; Albanes D; Purdue MP; Abnet CC; Chatterjee N; Horst RL; Hollis BW; Huang WY; Shikany JM; Hayes RB;
    J Natl Cancer Inst; 2008 Jun; 100(11):796-804. PubMed ID: 18505967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting serum vitamin D concentrations based on self-reported lifestyle factors and personal attributes.
    Ho V; Danieli C; Abrahamowicz M; Belanger AS; Brunetti V; Delvin E; Lacaille J; Koushik A
    Br J Nutr; 2018 Oct; 120(7):803-812. PubMed ID: 30079855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating 25-hydroxyvitamin D, vitamin D binding protein and risk of advanced and lethal prostate cancer.
    Yuan C; Shui IM; Wilson KM; Stampfer MJ; Mucci LA; Giovannucci EL
    Int J Cancer; 2019 May; 144(10):2401-2407. PubMed ID: 30411792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations of circulating 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and vitamin D pathway genes with prostate-specific antigen progression in men with localized prostate cancer undergoing active monitoring.
    Gilbert R; Metcalfe C; Fraser WD; Lewis S; Donovan J; Hamdy F; Neal DE; Lane JA; Martin RM; Tilling K
    Eur J Cancer Prev; 2013 Mar; 22(2):121-5. PubMed ID: 22955340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating 25-Hydroxyvitamin D Concentration and Risk of Breast, Prostate, and Colorectal Cancers: The Melbourne Collaborative Cohort Study.
    Heath AK; Hodge AM; Ebeling PR; Eyles DW; Kvaskoff D; Buchanan DD; Giles GG; Williamson EJ; English DR
    Cancer Epidemiol Biomarkers Prev; 2019 May; 28(5):900-908. PubMed ID: 30842127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer.
    Li H; Stampfer MJ; Hollis JB; Mucci LA; Gaziano JM; Hunter D; Giovannucci EL; Ma J
    PLoS Med; 2007 Mar; 4(3):e103. PubMed ID: 17388667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and subsequent risk of prostate cancer.
    Platz EA; Leitzmann MF; Hollis BW; Willett WC; Giovannucci E
    Cancer Causes Control; 2004 Apr; 15(3):255-65. PubMed ID: 15090720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma levels of 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D and the risk of prostate cancer.
    Jacobs ET; Giuliano AR; Martínez ME; Hollis BW; Reid ME; Marshall JR
    J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):533-7. PubMed ID: 15225833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D-related genetic variation, plasma vitamin D, and risk of lethal prostate cancer: a prospective nested case-control study.
    Shui IM; Mucci LA; Kraft P; Tamimi RM; Lindstrom S; Penney KL; Nimptsch K; Hollis BW; Dupre N; Platz EA; Stampfer MJ; Giovannucci E
    J Natl Cancer Inst; 2012 May; 104(9):690-9. PubMed ID: 22499501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum 25-OH vitamin D levels and risk of developing prostate cancer in older men.
    Barnett CM; Nielson CM; Shannon J; Chan JM; Shikany JM; Bauer DC; Hoffman AR; Barrett-Connor E; Orwoll E; Beer TM
    Cancer Causes Control; 2010 Aug; 21(8):1297-303. PubMed ID: 20383574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative importance of summer sun exposure, vitamin D intake, and genes to vitamin D status in Dutch older adults: The B-PROOF study.
    Brouwer-Brolsma EM; Vaes AMM; van der Zwaluw NL; van Wijngaarden JP; Swart KMA; Ham AC; van Dijk SC; Enneman AW; Sohl E; van Schoor NM; van der Velde N; Uitterlinden AG; Lips P; Feskens EJM; Dhonukshe-Rutten RAM; de Groot LCPGM
    J Steroid Biochem Mol Biol; 2016 Nov; 164():168-176. PubMed ID: 26275945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The epidemiology of vitamin D and cancer incidence and mortality: a review (United States).
    Giovannucci E
    Cancer Causes Control; 2005 Mar; 16(2):83-95. PubMed ID: 15868450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective study of plasma 25-hydroxyvitamin D concentration and prostate cancer risk.
    Deschasaux M; Souberbielle JC; Latino-Martel P; Sutton A; Charnaux N; Druesne-Pecollo N; Galan P; Hercberg S; Le Clerc S; Kesse-Guyot E; Ezzedine K; Touvier M
    Br J Nutr; 2016 Jan; 115(2):305-14. PubMed ID: 26568368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dairy intake and 1,25-dihydroxyvitamin D levels in men at high risk for prostate cancer.
    Tseng M; Giri V; Watkins-Bruner D; Giovannucci E
    Cancer Causes Control; 2009 Dec; 20(10):1947-54. PubMed ID: 19578936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variation in the vitamin d pathway in relation to risk of prostate cancer--results from the breast and prostate cancer cohort consortium.
    Mondul AM; Shui IM; Yu K; Travis RC; Stevens VL; Campa D; Schumacher FR; Ziegler RG; Bueno-de-Mesquita HB; Berndt S; Crawford ED; Gapstur SM; Gaziano JM; Giovannucci E; Haiman CA; Henderson BE; Hunter DJ; Johansson M; Key TJ; Le Marchand L; Lindström S; McCullough ML; Navarro C; Overvad K; Palli D; Purdue M; Stampfer MJ; Weinstein SJ; Willett WC; Yeager M; Chanock SJ; Trichopoulos D; Kolonel LN; Kraft P; Albanes D
    Cancer Epidemiol Biomarkers Prev; 2013 Apr; 22(4):688-96. PubMed ID: 23377224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ambient UVB Dose and Sun Enjoyment Are Important Predictors of Vitamin D Status in an Older Population.
    O'Sullivan F; Laird E; Kelly D; van Geffen J; van Weele M; McNulty H; Hoey L; Healy M; McCarroll K; Cunningham C; Casey M; Ward M; Strain JJ; Molloy AM; Zgaga L
    J Nutr; 2017 May; 147(5):858-868. PubMed ID: 28331054
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.